Effects of teneligliptin for atherosclerosis-related biomarkers in patients with type 2 diabetes mellitus

Effects of teneligliptin for atherosclerosis-related biomarkers in patients with type 2 diabetes mellitus - atherosclerosis and teneligliptin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009905

Enrollment

Registered

2013-02-10

Start date

2013-02-10

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

teneligliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: allergy

Design outcomes

Primary

Measure	Time frame
assessment of atherosclerosis-related miomarkers	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026